Chemcon Q2 FY23 revenue down 5.4%; Profit down 46.6%
Chemical

Chemcon Q2 FY23 revenue down 5.4%; Profit down 46.6%

Q2 FY23 business performance has been slow primarily due to lower volume offtake from pharmaceutical manufacturers

  • By ICN Bureau | November 14, 2022

Chemcon Speciality Chemicals Ltd., a leading manufacturer of specialized chemicals, Q2 FY23 revenue was down by 5.4% to reach Rs. 57.9 crore whereas profit was down 46.6% to reach Rs. 7.8 crore.   

Commenting on the results, Kamal Aggarwal, Chairman & MD said, “Q2 FY23 business performance has been slow primarily due to lower volume offtake from pharmaceutical manufacturers. Most of our clients are facing challenges due to adverse pricing scenarios across formulation & softening of demand. For Q2 FY23, we have registered a revenue of Rs. 58 crore for the quarter as both HMDS & CMIC have underperformed in the domestic market. On the other hand, robust performance in the export market has partly negated the subdued performance. Also, inorganic bromides have been affected marginally due to inconsistent sourcing of key raw material bromine."

"As a part of diversification strategy and business expansion, we have successfully commenced the commercial production of Bromobenzene at P9 facility which will cater to Agrochemical manufacturers in the global market. With the expansion of Bromobenzene, we will be adding Organic Bromides in our product basket. We are awaiting necessary approvals from regulatory authorities for another pharma chemical, Guanine at P9 Unit. We will be adding a few other chemicals which are imported in India at P10 Unit and expect to commence production by Q1FY24. Recently, we have purchased a land parcel at Gothda, near Vadodara for future leg of expansion and invested in a solar power plant for captive purpose which will reduce our power cost," said Aggarwal.

"Over the years, we have invested in the company to improve the product basket and add meaningful capacities. The company is also looking to establish a vast presence in the export market with a diversified product mix. India imports many pharmaceutical chemicals, which offers plenty of space for a producer like us to become a long-term trustworthy and sustainable domestic partner,” added Aggarwal.

Chemcon Speciality Chemicals Ltd., manufacturer of specialized chemicals, such as HMDS & CMIC which are predominantly used in the pharmaceuticals industry and inorganic bromides, namely Calcium Bromide, Zinc Bromide and Sodium Bromide, which are predominantly used as completion fluids in the oilfields industry.

In terms of production in the CY2019, the company was the only manufacturer of HMDS in India and was the third largest manufacturer of HMDS worldwide. The company is the largest manufacturer of CMIC in India and the second largest manufacturer of CMIC worldwide.

Register Now to Attend NextGen Chemicals & Petrochemicals Summit 2024, 11-12 July 2024, Mumbai

Other Related stories

Startups

Petrochemical

Energy

Digitization